首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Mental health clinician

缩写:

ISSN:2168-9709

e-ISSN:

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引477
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Marketa Marvanova Marketa Marvanova
Background: Perampanel is a selective, noncompetitive amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor antagonist indicated for management of partial-onset and primary generalized seizures in epilepsy...
Azita Alipour,Puja Baldev Patel,Zaheera Shabbir et al. Azita Alipour et al.
Introduction: Synthetic cannabinoids (SCs) are psychoactive substances that are gaining popularity for their availability and lack of detection by standardized drug tests. Although some users may perceive SCs as safer alt...
Stephanie V Phan,Yelena Lugin,Katie Morgan Stephanie V Phan
Introduction: Antipsychotics are commonly used during hospitalization to manage a variety of acute indications and may be inadvertently continued at discharge. The purpose of this study was to identify the rate at which p...
Nicole M Daniel,Kim Walsh,Henry Leach et al. Nicole M Daniel et al.
Introduction: Many medications commonly prescribed in psychiatric hospitals can cause QTc-interval prolongation, increasing a patient's risk for torsades de pointes and sudden cardiac death. There is little guidance in th...
Jill L Nofziger,Chris Paxos,Jessica Emshoff et al. Jill L Nofziger et al.
Introduction: Dextromethorphan (DXM), an N-methyl-D-aspartate receptor antagonist, may have ketamine-like antidepressant effects. Dextromethorphan is extensively metabolized via cytochrome P450 (CYP) 2D6, and its half-lif...
Samantha Maryan,Michelle Harms,Erin McAllister et al. Samantha Maryan et al.
Introduction: In an effort to establish clinical support for providers prescribing clozapine and to help reverse the national decline in clozapine utilization, a clinical pharmacist began seeing half the clozapine clinic ...
Deanna L Kelly,Raymond C Love Deanna L Kelly
Clozapine is an antipsychotic that exhibits superior efficacy and effectiveness for those with schizophrenia and other serious mental illness. However, its side-effect profile and administrative burdens present challenges to its use. In the...
Katherine Koller Katherine Koller
Despite psychomotor restlessness and akathisia being an occasionally reported side effect of antidepressants as a class, and mirtazapine specifically, there is no general consensus on the best treatment approach. Propranolol may prove to be...
David Dadiomov,Kelly Lee David Dadiomov
Introduction: Suicidality and self-injurious behavior afflict patients with a wide variety of psychiatric illnesses. Currently, there are few pharmacologic treatments for suicidality and self-injurious behavior and none t...
Michael Shuman,Athena Chukwu,Nathan Van Veldhuizen et al. Michael Shuman et al.
Introduction: Mirtazapine is an antidepressant with US Food and Drug Administration approval for management of major depressive disorder. Low doses of mirtazapine are often used for management of insomnia, with higher dos...